drugset / Trial / NCT07249554
Combination Therapy for Alcohol Use Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This human laboratory study will collect preliminary safety and efficacy data from a sample of participants enrolled in a 4-week in-patient treatment program for alcohol use disorder.
Timeline
- Start
- 2026-09
- Primary completion
- 2028-07
- Completion
- 2028-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | — | Oral |
| Subject | Semaglutide | Peptide | 7 mg | Oral |